Oncotelic Therapeutics, Inc. (OTLC)

Oncotelic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	17	37	14	15	18	63
Market Cap Growth	-16.51%	160.46%	-6.64%	-13.25%	-71.94%	225.64%
Enterprise Value	30	50	26	27	27	70
Last Close Price	0.04	0.08	0.04	0.04	0.04	0.17
PE Ratio	0.06	0.15	-	-	3.45	-
PS Ratio	-	-	-	218.13	-	-
PB Ratio	0.06	0.14	1.91	1.32	0.92	7.69
P/TBV Ratio	0.07	0.14	2.61	2.49	2.40	-
EV/Sales Ratio	-	-	-	384.58	-	-
Debt / Equity Ratio	0.05	0.05	1.75	1.08	0.59	1.10
Net Debt / Equity Ratio	0.05	0.05	1.74	1.07	0.57	1.03
Net Debt / EBITDA Ratio	-	-	-	-22.47	-1.97	-0.93
Asset Turnover	-	-	-	0.00	-	-
Quick Ratio	0.01	0.01	0.01	0.01	0.02	0.04
Current Ratio	0.07	0.07	0.01	0.02	0.02	0.04
Return on Equity (ROE)	185.00%	185.00%	-50.08%	-53.28%	34.20%	-101.92%
Return on Assets (ROA)	-0.89%	-0.89%	-0.83%	-1.07%	-11.74%	-24.13%
Return on Invested Capital (ROIC)	-1.39%	-1.39%	-1.69%	-2.08%	-23.98%	-54.90%
Return on Capital Employed (ROCE)	-0.80%	-0.80%	-5.00%	-4.20%	-29.20%	-111.90%
Earnings Yield	1469.09%	671.40%	-31.74%	-51.76%	28.95%	-14.97%
Buyback Yield / Dilution	-4.12%	-4.12%	-5.29%	16.01%	-50.89%	-244.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.